One third Patients of ACS potentially eligible for PCSK9 Inhibitors Treatment, finds study MD Bureau19 May 2021 9:00 AM ISTPrevious studies have shown that the PCSK9 (proprotein convertase subtilisin/kexin type 9) inhibitors evolocumab and alirocumab have been associated...
Common BP drug may raise risk of Lung Cancer: Study MD Bureau19 Jan 2021 7:10 AM ISTAngiotensin-converting enzyme inhibitors (ACEIs) are effective drugs used in the treatment of hypertension. Although these drugs are relatively safe...
